Author Correction: CCR5AS lncRNA variation differentially regulates CCR5, influencing HIV disease outcome

Smita Kulkarni; Alexandra Lied; Viraj Kulkarni; Marijana Rucevic; Maureen P Martin; Victoria Walker-Sperling; Stephen K Anderson; Rodger Ewy; Sukhvinder Singh; Hoang Nguyen; Paul J McLaren; Mathias Viard; Vivek Naranbhai; Chengcheng Zou; Zhansong Lin; Hiroyuki Gatanaga; Shinichi Oka; Masafumi Takiguchi; Chloe L Thio; Joseph Margolick; Gregory D Kirk; James J Goedert; W Keith Hoots; Steven G Deeks; David W Haas; Nelson Michael; Bruce Walker; Sylvie Le Gall; Fatema Z Chowdhury; Xu G Yu; Mary Carrington

doi:10.1038/s41590-019-0516-9

Author Correction: CCR5AS lncRNA variation differentially regulates CCR5, influencing HIV disease outcome

Nat Immunol. 2019 Nov;20(11):1555. doi: 10.1038/s41590-019-0516-9.

Authors

Smita Kulkarni^{1

2}, Alexandra Lied³, Viraj Kulkarni^{4

3}, Marijana Rucevic^{3

5}, Maureen P Martin⁶, Victoria Walker-Sperling⁷, Stephen K Anderson⁶, Rodger Ewy⁴, Sukhvinder Singh⁴, Hoang Nguyen⁴, Paul J McLaren^{8

9}, Mathias Viard⁶, Vivek Naranbhai³, Chengcheng Zou¹⁰, Zhansong Lin¹⁰, Hiroyuki Gatanaga^{10

11}, Shinichi Oka^{10

11}, Masafumi Takiguchi¹⁰, Chloe L Thio¹², Joseph Margolick¹³, Gregory D Kirk¹⁴, James J Goedert¹⁵, W Keith Hoots¹⁶, Steven G Deeks¹⁷, David W Haas¹⁸, Nelson Michael¹⁹, Bruce Walker^{3

20

21}, Sylvie Le Gall³, Fatema Z Chowdhury³, Xu G Yu³, Mary Carrington^{22

23}

Affiliations

¹ Texas Biomedical Research Institute, San Antonio, TX, USA. skulkarni@txbiomed.org.
² Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA. skulkarni@txbiomed.org.
³ Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.
⁴ Texas Biomedical Research Institute, San Antonio, TX, USA.
⁵ Olink Proteomic, Watertown, MA, USA.
⁶ Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
⁷ Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA.
⁸ J.C. Wilt Infectious Disease Research Centre, Public Health Agency of Canada, Winnipeg, MB, Canada.
⁹ Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB, Canada.
¹⁰ Center for AIDS Research, Kumamoto University, Kumamoto, Japan.
¹¹ AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.
¹² Department of Medicine, Johns Hopkins University, Baltimore, MD, USA.
¹³ Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
¹⁴ Department of Epidemiology, Johns Hopkins University, Baltimore, MD, USA.
¹⁵ Epidemiology and Biostatistics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
¹⁶ Division of Blood Diseases and Resources, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
¹⁷ San Francisco General Hospital Medical Center, San Francisco, CA, USA.
¹⁸ Vanderbilt University School of Medicine, Nashville, TN, USA.
¹⁹ US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA.
²⁰ Howard Hughes Medical Institute, Chevy Chase, MD, USA.
²¹ Institute for Medical Engineering and Sciences, Massachusetts Institute of Technology, Cambridge, MA, USA.
²² Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA. carringm@mail.nih.gov.
²³ Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA. carringm@mail.nih.gov.

PMID: 31548709
DOI: 10.1038/s41590-019-0516-9

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Publication types

Published Erratum

Grants and funding

R21 AI120900/AI/NIAID NIH HHS/United States